Inogen (INGN) Misses Q1 EPS by 1c ; Offers Guidance

Inogen (NASDAQ: INGN) reported Q1 EPS of ($0.30), $0.01 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $85.1 million versus the consensus estimate of $82.35 million.

GUIDANCE:

Inogen sees Q2 2026 revenue of $94-97 million, versus the consensus of $97.25 million.

Inogen sees FY2026 revenue of $366-373 million, versus the consensus of $369.2 million.

For earnings history and earnings-related data on Inogen (INGN) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Battery X Metals adds auto industry advisor to board
• PreveCeutical closes second tranche of private placement for $245,000